IMMP
Immutep Limited (IMMP) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
IMMP’s R&D intensity is high versus commercial-stage peers, supporting lower near-term manufacturing footprint but also indicating a resource-heavy development model.
The company’s low leverage reduces balance-sheet pressure for environmental compliance spending relative to more indebted peers, though this is not a direct environmental advantage.
Negative gross profit margin suggests limited operating scale versus peers, which can constrain funding for emissions, waste, and process-improvement initiatives.
No disclosed post-August 2025 environmental controversies were provided, so the assessment relies on capital-allocation and operating-profile indicators rather than incident history.
Social
High R&D spending relative to revenue can support patient access and clinical development activity, but it also signals a cost structure that is less efficient than peers.
Stock-based compensation is elevated versus revenue, which can aid talent retention in a competitive biotech labor market but may dilute alignment versus peers.
The absence of provided workforce, safety, or product-access disclosures limits evidence of stronger social positioning relative to better-disclosed peers.
Negative gross margin indicates a pre-commercial profile that can delay broader stakeholder benefits versus peers with more advanced product monetization.
Governance
Very low debt-to-equity suggests conservative capital structure management versus more leveraged peers, reducing refinancing and covenant-related governance risk.
Net debt to EBITDA remains modest, indicating limited balance-sheet stress and fewer incentives for aggressive governance decisions than in highly levered peers.
Stock-based compensation at nearly 20% of revenue is material versus peers, increasing dilution sensitivity and making compensation oversight more important.
The provided data do not include board independence, audit quality, or controversy history, so governance strength is inferred mainly from capital-discipline metrics.
Overall Score
IMMP’s ESG profile is broadly average versus peers, with conservative leverage supporting governance, while limited disclosure and a development-stage operating model cap stronger relative positioning.
Score Driver: Conservative Leverage And Modest Balance-Sheet Risk Versus Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Immutep Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.